Biosensors Market by Product (Wearable biosensors and Non- Wearable biosensors), Technology (Electrochemical Biosensors, Optical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, and Nanomechanical Biosensors): Global Opportunity Analysis and Industry Forecast, 20192026
- Published Date: 2020-11-18
- Report ID: 18195
- Pages: 163
-
Format:
The global biosensors market was valued at $17,500.0 million in 2018, and is expected to reach $38,600.2 million by 2026, registering a CAGR of 10.4% from 2019 to 2026. Biosensors are medical devices that are primarily used to sense or detect the presence or concentration of biological substances, such as a biomolecule or a microorganism. They are analytical devices that can convert a biological response into an electrical signal. Biosensors majorly comprise three parts, including a component that identifies an analyte and produces signal, a signal transducer, and a reader device. Biosensors find their applications in food & beverages, environmental monitoring, home care diagnostics. and various nanomechanical biosensors. In addition, biosensor applications are also widely dominant in the field of plant biology to study metabolic processes.
Significant rise in chronic diseases such as diabetes across the globe, surge in biotechnology R&D, and increased demand for home care devices are the major factors that drive the biosensors market growth. In addition, considerable increase in preference of biosensors in glucose monitoring devices contributes to the market growth. However, high cost associated with these devices and lack of inclination toward adoption of new treatment devices are the major factors anticipated to hamper the market growth. On the contrary, technological advancements in biosensors to make them portable and easy to handle is anticipated to create lucrative opportunities in the future.
The market is segmented on the basis of product, technology and region. Based on product, the global biosensors market is divided into wearable biosensors and nonwearable biosensors. Based on technology, the market is classified into electrochemical biosensors, optical biosensors, piezoelectric biosensors, thermal biosensors and nanomechanical biosensors. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Prominent players in the market have adopted various strategies such as product approval and partnership for maintaining their share in the global biosensors market, thereby addressing the evolving healthcare needs among patients and healthcare providers. Some of the key players of the market include Abbott Laboratories, AgaMatrix Holdings LLC, DowDupont Inc. (DuPont de Nemours, Inc.), F. Hoffmann-La Roche Ltd., General Electric (Biacore, Inc.), LifeScan, Inc., Medtronic Plc., Nova Biomedical, PHC Holdings Co., Ltd. (Ascensia Diabetes Care Holdings AG), and Siemens Healthcare.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
KEY MARKET SEGMENTS
By Product
Wearable Biosensors
Non- Wearable Biosensors
By Technology
Electrochemical Biosensors
Optical Biosensors
Piezoelectric Biosensors
Thermal Biosensors
Nanomechanical Biosensors
By Region
North America
o U.S.
o Canada
o Mexico
Europe
o Germany
o France
o UK
o Italy
o Rest of Europe
Asia Pacific
o Japan
o China
o India
o Rest of Asia-Pacific
LAMEA
o Brazil
o Saudi Arabia
o South Africa
o Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
Abbott Laboratories
AgaMatrix Holdings LLC
DowDupont Inc
F. Hoffmann-La Roche Ltd.
General Electric
LifeScan, Inc.
Medtronic Plc
Nova Biomedical
PHC Holdings Co., Ltd
Siemens Healthcare
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Research methodology
1.3.1.Secondary research
1.3.2.Primary research
1.3.3.Analyst Tools and Models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porters five forces analysis
3.3.1.Moderate bargaining power of buyers
3.3.2.Low bargaining power of suppliers
3.3.3.Moderate threat of substitutes
3.3.4.Low threat of new entrants
3.3.5.Moderate competitive rivalry
3.4.Top player positioning
3.5.Market Dynamics
3.5.1.Drivers
3.5.1.1.Rise in R&D investments
3.5.1.2.Development of nanotechnology-based biosensors
3.5.2.Restraint
3.5.2.1.High cost associated with R&D
3.5.3.Opportunity
3.5.3.1.Various growth opportunities in emerging economies
CHAPTER 4:BIOSENSORS MARKET, BY PRODUCT
4.1.Overview
4.1.1.Market size and forecast
4.2.Wearable biosensors
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast
4.2.3.Market share analysis, by country
4.3.Non wearable biosensors
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast
4.3.3.Market share analysis, by country
CHAPTER 5:BIOSENSORS MARKET, BY TECHNOLOGY
5.1.Overview
5.1.1.Market size and forecast
5.2.Electrochemical Biosensors
5.2.1.Market size and forecast
5.2.2.Market share analysis, by country
5.3.Optical Biosensors
5.3.1.Market size and forecast
5.3.2.Market share analysis, by country
5.4.Piezoelectric Biosensors
5.4.1.Market size and forecast
5.4.2.Market share analysis, by country
5.5.Thermal Biosensors
5.5.1.Market size and forecast
5.5.2.Market share analysis, by country
5.6.Nanomechanical Biosensors
5.6.1.Market size and forecast
5.6.2.Market share analysis, by country
CHAPTER 6:BIOSENSORS MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by country
6.2.3.Market size and forecast, by technology
6.2.4.Market size and forecast, by product
6.2.5.U.S.
6.2.5.1.U.S. market size and forecast, by technology
6.2.5.2.U.S. market size and forecast, by product
6.2.6.Canada
6.2.6.1.Canada market size and forecast, by technology
6.2.6.2.Canada market size and forecast, by product
6.2.7.Mexico
6.2.7.1.Mexico market size and forecast, by technology
6.2.7.2.Mexico market size and forecast, by product
6.3.Europe
6.3.1.Key growth factors and opportunities
6.3.2.Market size and forecast, by country
6.3.3.Market size and forecast, by technology
6.3.4.Market size and forecast, by product
6.3.5.Germany
6.3.5.1.Germany market size and forecast, by technology
6.3.5.2.Germany market size and forecast, by product
6.3.6.France
6.3.6.1.France market size and forecast, by technology
6.3.6.2.France market size and forecast, by product
6.3.7.UK
6.3.7.1.UK market size and forecast, by technology
6.3.7.2.UK market size and forecast, by product
6.3.8.Italy
6.3.8.1.Italy market size and forecast, by technology
6.3.8.2.Italy market size and forecast, by product
6.3.9.Rest of Europe
6.3.9.1.Rest of Europe market size and forecast, by technology
6.3.9.2.Rest of Europe market size and forecast, by product
6.4.Asia-Pacific
6.4.1.Key growth factors and opportunities.
6.4.2.Market size and forecast, by country
6.4.3.Market size and forecast, by technology
6.4.4.Market size and forecast, by product
6.4.5.Japan
6.4.5.1.Japan market size and forecast, by technology
6.4.5.2.Japan market size and forecast, by product
6.4.6.China
6.4.6.1.China market size and forecast, by technology
6.4.6.2.China market size and forecast, by product
6.4.7.India
6.4.7.1.India market size and forecast, by technology
6.4.7.2.India market size and forecast, by product
6.4.8.Rest of Asia-Pacific
6.4.8.1.Rest of Asia-Pacific market size and forecast, by technology
6.4.8.2.Rest of Asia-Pacific market size and forecast, by product
6.5.LAMEA
6.5.1.Key growth factors and opportunities
6.5.2.Market size and forecast, by country
6.5.3.Market size and forecast, by technology
6.5.4.Market size and forecast, by product
6.5.5.Brazil
6.5.5.1.Brazil market size and forecast, by technology
6.5.5.2.Brazil market size and forecast, by product
6.5.6.Saudi Arabia
6.5.6.1.Saudi Arabia market size and forecast, by technology
6.5.6.2.Saudi Arabia market size and forecast, by product
6.5.7.South Africa
6.5.7.1.South Africa market size and forecast, by technology
6.5.7.2.South Africa market size and forecast, by product
6.5.8.Rest of LAMEA
6.5.8.1.Rest of LAMEA market size and forecast, by technology
6.5.8.2.Rest of LAMEA market size and forecast, by product
CHAPTER 7:COMPANY PROFILES
7.1.ABBOTT LABORATORIES
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.AGAMATRIX HOLDINGS LLC
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Business performance
7.2.1.Key strategic moves and developments
7.3.DOWDUPONT INC. (DUPONT DE NEMOURS, INC.)
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product Portfolio
7.3.5.Business performance
7.4.F. HOFFMANN-LA ROCHE LTD.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.4.6.Key strategic moves and developments
7.5.GENERAL ELECTRIC (BIACORE, INC.)
7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.6.LIFESCAN, INC.
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
7.7.MEDTRONIC PLC.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.8.NOVA BIOMEDICAL
7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Business performance
7.8.6.Key strategic moves and developments
7.9.PHC HOLDINGS CO., LTD. (ASCENSIA DIABETES CARE HOLDINGS AG)
7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.10.SIEMENS
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
